WCO02. Preliminary results of vitamin D blood levels in a portuguese young adult population  by Barbosa, Ana Paula et al.
 X Congresso Português de Osteoporose 9
Methods: Research guidelines, meta-analysis (MA), systematic 
reviews (SR) and randomized controlled trials (RCT) in English and 
Portuguese, in PubMed and medical databases based on evidence. 
MeSH terms used: “Parkinson’s disease” and “osteoporosis”. Articles 
published between January 2006 and January 2016 were selected.
Results: Four articles were obtained, but only three met the in-
clusion criteria. One MA, one SR and one RCT showed a relation be-
tween PD and osteoporosis, bone mineral density (BMD) and fracture 
risk. Patients with PD have an increased risk for osteoporosis when 
compared to the general population. It was also evident in PD: lower 
BMD, lower vitamin D levels and an increased risk of fractures. The 
reduction of bone mass in PD seems to be mainly caused by limited 
mobility. Endocrine (such as vitamin D deficiency), nutritional and 
iatrogenic factors also play an important role in the depletion of bone 
mass. Female sex, PD duration and severity, advanced age and low 
body mass index were associated with severe osteoporosis.
Conclusions: The available evidence supports an increased risk 
of osteoporosis among PD patients. This fact should alert the clini-
cian about the importance of osteoporosis screening in PD patients. 
However, more studies are needed, with high methodological qual-
ity and patient oriented, in order to demonstrate the health benefit 
of osteoporosis screening/early treatment in PD patients.
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Introdução: As ortóteses de tronco são um componente do trata-
mento conservador da osteoporose, sobretudo quando o doente de-
senvolve fracturas osteoporóticas. Podem ter indicação numa fase 
aguda, subaguda ou crónica da doença. Dada a escassez de evidência, 
na prática clínica ainda persistem dúvidas quanto ao tipo de ortóte-
se mais indicado, quando se deve utilizar e durante quanto tempo.
Objectivos: Avaliar o papel das ortóteses de tronco no doente com 
osteoporose e as suas principais indicações.
Métodos: Revisão da literatura publicada nas principais bases de 
dados médicas até Março de 2016.
Resultados: De um total de 4,236 artigos inicialmente identifica-
dos, foram incluidos 12 artigos para análise mais pormenorizada. 
A literatura evidencia o benefício das ortóteses no controlo da dor, 
suporte estrutural, melhoria da postura, propriocepção e equilíbrio, 
contribuindo para a prevenção de deformidades e de novas fracturas 
osteoporóticas. Os autores descrevem as principais ortóteses de 
tronco utilizadas nos doentes com osteoporose, particularizando as 
indicações dos diferentes tipos de ortótese.
Conclusões: As ortóteses de tronco apresentam efeito benéfico 
significativo em certas situações clínicas. Contudo, a sua prescrição 
deve ser individualizada a cada doente e requer um vasto conheci-
mento da anatomia, biomecânica, cinesiologia e patologia. São ne-
cessários mais estudos com qualidade metodológica que sustentem 
a evidência do benefício das ortóteses do tronco, nomeadamente a 
longo prazo.
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Introduction: In recent years there has been a number of studies 
examining the correlation between vitamin D status and skeletal 
muscles. However, there are many different approaches to the role 
of vitamin D metabolism and function of skeletal muscles.
Objectives: The aim of the research conducted at the SI “D.F. Che-
botarev Institute of Gerontology NAMS of Ukraine” was to study the 
correlation between skeletal muscles and vitamin D level in women 
of different ages.
Methods: The study involved 122 healthy women aged 20 to 
83 years. According to the gerontological classification, the exam-
ined women were divided into groups: younger – up to 44 years 
(n = 35), middle – 45-59 years old (n = 26), older – 60-74 years 
(n = 44), senile age – 75-89 years (n = 17). Lean mass of the total 
body, upper and lower extremities was evaluated using Dual X-ray 
absorptiometry (Prodigy, GEHC Lunar, Madison, WI, USA). Strength 
of skeletal muscle was evaluated using springy carpal dynamome-
ter. To determine the functional capacity of skeletal muscle we used 
a «four-meter» test. To determine the level of 25(OH)D electro-
chemiluminescent method was used with Elecsys 2010 analyzer 
(Roche Diagnostics, Germany).
Results: We determined a significant correlation between pa-
rameters of lean mass (r = 0.45; t = 2.08; p = 0.05) and the level of 
vitamin D in women of middle (45-59 years) age; skeletal muscle 
functionality (r = -0.51; t = -2.29; p = 0.04) and the level of vitamin D 
in women of older (60-74 years) age. We did not find the significant 
correlation between parameters of muscle strength and level of vi-
tamin D.
Conclusions: Significant correlation between parameters of lean 
mass, skeletal muscle functionality and the level of vitamin D was 
determined in women of middle and older age.
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Introduction: The hormone “vitamin D” [25(OH)D] has been ex-
tensively studied worldwide lately, in order to try to define its ade-
quate or inadequate blood levels and their eventual clinical 
significance. Although the skeletal consequences of the low levels 
are well known, the association with increased risk of cancer and 
cardiovascular diseases is far from clarified. It is known that vitamin 
D blood levels vary through life, but in Portugal the studies about it 
in different aged populations are scarce.
Objectives: To study the variation of vitamin D blood levels, 
through summer and winter and to relate it to biochemical and hor-
monal parameters, in a Portuguese young adult population.
Methods: In 268 healthy adults (190 women, 78 men), aged 18 
to 35 years, fasting blood was taken to measure 25(OH)D, iPTH, 
calcium, phosphorus, liver and renal functions, TSH and other 
hormones, in summer 2014 and in the winter after. The hormones 
were analyzed by Liaison technology. To define abnormal 25(OH)
D we used the “Endocrine Society 2011” criteria. Adequate statis-
tical tests were used to describe the summer/winter groups and 
their differences. Statistical significance was considered for 
p < 0.05.
Results: The mean (± SD) 25(OH)D in the vitamin D groups and 
the n (%) in each group (table). Significant relations were found for 
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both 25(OH)D (r = 0.683; p = 0.001) and PTHi (r = 0.467; p = 0.001) 
blood levels between summer and winter.
Groups of Vitamin D  
ng/ml
Normal  
(> 30)
Insufficiency 
(21-29)
Deficiency  
(< 20)
Summer 37.0 (± 1.0) 24.7 (± 0.27) 16.9 (± 4.1)
Winter 33.2 (± 0.8) 23.4 (± 0.4) 14.3 (± 0.3)
Summer n (%) 48 (24.6) 100 (51.3) 47 (24.1)
Winter n (%) 3 (1.9) 23 (14.4) 134 (83.8)
Conclusions: Significant variations summer/winter of both 
25(OH)D and iPTH blood levels, were found in this healthy young 
adult population. Also, the means of 25(OH)D were relatively low, 
suggesting that many young adults have already levels of deficiency/
insufficiency, such as was described in other south European coun-
tries; however, the clinical significance of such inadequate levels still 
remains unclarified.
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Introduction: BMD and blood vitamin D concentrations decline 
slowly with ageing, as falls and osteoporotic fractures increase 
among elderly people. The bone quality may be accessed by trabec-
ular bone score (TBS); together, TBS and DXA may evidence bone 
strength. However, data about the influence of vitamin D on the TBS 
are scarce.
Objectives: To evaluate the influence of the blood vitamin D lev-
els on the BMD and TBS in normal men.
Methods: The bone mineral content (BMC, g), BMD (g/cm2), and 
TBS (obtained from DXA scan) at the lumbar spine were evaluated in 
a group of normal men aged ≥ 40 years. Fasting blood collections 
were performed for measurements of the osteocalcin, 25(OH)D and 
iPTH concentrations. These men were divided in the normal, low 
BMD and osteoporosis groups, as well as in the normal, insufficiency 
and deficiency vitamin D groups (ES Guidelines). Total body fat and 
lean masses were also calculated. Adequate statistical tests were 
used (statistical significance p < 0.05).
Results: Men of deficiency group were heavier and with the lower 
TBS. The mean (± SD) osteocalcin, iPTH, 25(OH)D and TBS of the BMD 
are shown in the table. Significant correlation coefficients were de-
tected between the blood 25(OH)D vs weight, vs total fat mass and 
vs TBS but not vs BMD.
Groups variable Normal (50.0%) Low BMD (41.1%) Osteoporosis (8.9%) p
Osteocalcin ng/ml 17.6 (± 1.6) 18.8 (± 1.7) 25.7 (± 3.7) NSD
iPTH pg/ml 46.5 (± 6.5) 61.4 (± 7.0) 60.5 (± 15.0) NSD
25(OH)D ng/ml 20.6 (± 1.8) 20.2 (± 2.0) 18.8 (± 4.4) NSD
TBS L1-L4 1.334 (± 0.1) 1.319 (± 0.1) 1.281 (± 0.1) NSD
Conclusions: Blood 25(OH)D levels may play an important role on 
the bone quality accessed by TBS in vitamin D deficient men, as they 
have worse bone quality. The data suggest that more studies are 
needed on larger cohort of men and it might be worth to investigate 
also elderly men with osteomalacia.
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Introduction: Patients with thyroid autoimmune diseases have 
lower blood level of vitamin D by comparison to a general popula-
tion. However, there are few studies examining vitamin D status in 
patients with subclinical and overt hyperthyroidism depending on 
the degree of disease compensation.
Objectives: The aim of this study was determination of blood 
25(OH)D level in patients with subclinical and overt hyperthyroid-
ism, and also his possible influence on disease progression.
Methods: 80 patients of reproductive age with thyrotoxicosis 
syndrome were recruited. The thyroid functional state was esti-
mated by means of determination of thyroid-stimulating hormone 
(TSH) basal concentrations and free thyroxine in the blood serum. 
Subjects were invited to attend quantitative ultrasound densitome-
try (Sahara), and a fasting blood sample from which osteocalcin, se-
rum N-terminal propeptide of type 1 procollagen and crosslinks 
were also measured.
Results: 25(OH)D level (14.9 ± 1.8 ng/ml) was significantly lower 
in patients with diffuse toxic goiter in the state of sub- and decom-
pensation, comparatively with the group of women with diffuse 
toxic goiter in the state of stabile thyrotoxicosis compensation (21.2 
± 2.4 ng/ml) and control group (23.9 ± 2.7 ng/ml). The results of cor-
relation analysis testify to the presence in patients with diffuse toxic 
goiter in the state of thyrotoxicosis sub- and decompensation signifi-
cant negative connection between blood 25(OH)D and level of thy-
rotropin receptor antibodies (r = -0.47; p < 0.05). Frequency of bone 
mineral density disorders in patients with thyrotoxicosis syndrome 
was 52.7%, including osteopenia in 40% and osteoporosis in 12.7%. 
A basic factor that results in the decline of bone mineral density in 
patients with thyrotoxicosis syndrome is excessive products of thy-
roid hormones, and also TSH-suppressive doses of levothyroxine.
Conclusions: The vitamin D blood level depends on the degree 
of thyrotoxicosis compensation. Significant association between 
25(OH)D range and level of thyrotropin receptor antibodies estab-
lished in the group of patients with an uncompensated thyrotoxi-
cosis.
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Introduction: Some recent epidemiological studies suggest an 
important role for vitamin D in the glycemic and lipid homeostasis.
Objectives: Longitudinal study to evaluate the possible effects of 
vitamin D supplementation in several cardio-metabolic and anthro-
pometric variables of people affected by type 2 diabetes mellitus.
Methods: 21 T2DM women treated with oral antidiabetics of the 
bone metabolic diseases out-patient clinic were evaluated before and 
one year after beginning the supplementation with vitamin D. 
Fasting blood was collected for 25-hydroxy-vitamin D [25(OH)D], 
glucose, HbA1c, total cholesterol, LDL- and HDL- cholesterol and trig-
lycerides measurements. Total body fat mass and fat percentage 
